PMID- 12472671 OWN - NLM STAT- MEDLINE DCOM- 20030110 LR - 20190818 IS - 0300-9475 (Print) IS - 0300-9475 (Linking) VI - 56 IP - 6 DP - 2002 Dec TI - Analysis of gene expression during maturation of immature dendritic cells derived from peripheral blood monocytes. PG - 593-601 AB - Dendritic cells (DCs) are the most important antigen-presenting cells. Many recent studies have compared the function of immature DCs (iDCs) and mature DCs (mDCs), but there have been few reports of the molecular changes that occur in DCs during maturation. Here, we report on differential gene expression in iDCs generated from peripheral blood monocytes compared with mDCs. Gene expression was evaluated using the differential display method after activation of iDCs with a low concentration of lipopolysaccharide (LPS) to induce maturation. Proteasome subunit alpha type 3 (PSMA3), transcription factor EC (TFEC) isoform and BTK region clone 2f10-rpi were transiently upregulated. Tryptophanyl-tRNA synthetase and CD63 antigen were upregulated for at least 24 h. Neuronal apoptosis inhibitory protein (NAIP) and transforming growth factor-beta-induced 68 kDa protein were downregulated. This is the first report of NAIP expression in human DCs. By comparing the expression of NAIP with that of other members of the inhibitor of apoptosis protein (IAP) family and the Bcl-2 family, only NAIP was found to be strongly expressed in iDCs before stimulation by LPS. PSMA3 was also induced in the DCs stimulated with immune complex. These findings might contribute to our understanding of DC maturation and the effectiveness of DC-based vaccines. FAU - Matsunaga, T AU - Matsunaga T AD - First Department of Internal Medicine, Sapporo Medical University, Sapporo, Japan. FAU - Ishida, T AU - Ishida T FAU - Takekawa, M AU - Takekawa M FAU - Nishimura, S AU - Nishimura S FAU - Adachi, M AU - Adachi M FAU - Imai, K AU - Imai K LA - eng PT - Comparative Study PT - Journal Article PL - England TA - Scand J Immunol JT - Scandinavian journal of immunology JID - 0323767 RN - 0 (Lipopolysaccharides) RN - 0 (Multienzyme Complexes) RN - 0 (NAIP protein, human) RN - 0 (Nerve Tissue Proteins) RN - 0 (Neuronal Apoptosis-Inhibitory Protein) RN - 0 (Proto-Oncogene Proteins c-bcl-2) RN - 0 (RNA, Messenger) RN - 0 (Transforming Growth Factor beta) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 3.4.22.- (Cysteine Endopeptidases) RN - EC 3.4.25.1 (Proteasome Endopeptidase Complex) SB - IM MH - Apoptosis MH - Cell Differentiation MH - Cells, Cultured MH - Cysteine Endopeptidases/metabolism MH - Dendritic Cells/classification/drug effects/*immunology MH - Gene Expression Profiling MH - Humans MH - Immunophenotyping MH - Kinetics MH - Lipopolysaccharides/pharmacology MH - Monocytes/*immunology MH - Multienzyme Complexes/metabolism MH - Nerve Tissue Proteins/biosynthesis/genetics MH - Neuronal Apoptosis-Inhibitory Protein MH - Polymerase Chain Reaction MH - Proteasome Endopeptidase Complex MH - Proto-Oncogene Proteins c-bcl-2/biosynthesis/genetics MH - RNA, Messenger/biosynthesis MH - Stem Cells/*immunology MH - Transforming Growth Factor beta/pharmacology MH - Tumor Necrosis Factor-alpha/pharmacology EDAT- 2002/12/11 04:00 MHDA- 2003/01/11 04:00 CRDT- 2002/12/11 04:00 PHST- 2002/12/11 04:00 [pubmed] PHST- 2003/01/11 04:00 [medline] PHST- 2002/12/11 04:00 [entrez] AID - 1179 [pii] AID - 10.1046/j.1365-3083.2002.01179.x [doi] PST - ppublish SO - Scand J Immunol. 2002 Dec;56(6):593-601. doi: 10.1046/j.1365-3083.2002.01179.x.